Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

TECH · Bio-Techne Corp

$72.08 -0.24% Sep 10 close
Detected setup Flat Base · Setup Score 93/100

Stand aside — setup invalidated

Setup score 93, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about TECH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$TECH

Bio-Techne Corp

Bio-Techne Corp is a large-cap Biotechnology company in the Health Technology sector with a market cap of $11B.

Health Technology Biotechnology stock Stage 2 · Advancing Base 1
$72.08 latest close
Verdict · setup score 93/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 93, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

TECH-0.24%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. +0.36 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-0.24% From the open-0.28% Range position0% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $72.08 -0.2% Sep 10 close
52W High $72.62 0.7% below high
Wks Since High 3w
Base Depth 0.7%
RS Rank 76 percentile of scan
SMA 50 $71.93
Avg Vol 3,497,367
Rel Vol (Sep 10) 1.09×
More stats
52W Low $43.19
Tight Wks 10
Base B1
SMA 200 $61.21
RS Line vs High -8.7%
RS Line Slope +2.5% ▲
Group Rank #15/58
ADR% 0.3%
ATR(14) $0.16 (0.2%)
Vol Pace (live) N/A
U/D Vol 0.92
A/D Days 14A / 7D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 98thpercentile of the 52-week range
$43.19low
$72.62high

TECH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for TECH.

Create Free Account

Technical Analysis Report Card

$TECH · $72.08 · as of 2026-09-10 · multi-factor read
70
/ 100
Technicals 70/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$71.93 ↑
100-day$62.72 ↑
200-day$61.21 ↑
Bullish (50 > 200)

RSI (14)

Reading55.1 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening
Histogram-0.176

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-8% · 0.6%
Squeeze — volatility compressing

Piercing the lower band — capitulation or strong selling. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.92 · Neutral
Rel volume1.09×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $72.4352-week high
Price · $72.08now
S · $70.49swing level
S · $54.20swing level
S · $50.56swing level

Fibonacci · Uptrend swing

23.6%$65.67
38.2%$61.38
50.0%$57.91
61.8%$54.43
78.6%$49.49

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for TECH — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishRS 80 (leader)
Want this read in a legend's voice? Ask a Legend about TECH
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini C

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $72.08, MA150 $60.51, MA200 $61.21
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $71.93, MA150 $60.51, MA200 $61.21
Failing evidence
1.2 150-day MA > 200-day MAMA150 $60.51 vs MA200 $61.21
2. Quarterly EPS growth ≥ 25%From SEPA scan
8/13 checks
Watch
O'Neil D

CANSLIM read: 4/8 pass; improvement is still needed.

Passing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B
L: RS rank ≥ 80 (IBD leadership)RS rank 80
Failing evidence
A: Annual earnings & revenue qualityRev -0.4%
S: Volume ≥ 40% above average on breakoutVolume ratio 1.09x
4/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $72.08 vs MA200 $61.21
Failing evidence
Volume expansion above averageVolume ratio 1.09x
6/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$72.08
Relative strengthRS 80
Failing evidence
Volume vs average1.09x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$72.08
Relative strengthRS 80
Failing evidence
Volume vs average1.09x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$72.08
Relative strengthRS 80
Failing evidence
Volume vs average1.09x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
122RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +8 A+
A: 13 D: 5 Net: +865 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY -0%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 80
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -0.7%

Method Playbook

Trade it like Minervini EXACT LEVELS · PRO
Minervini C · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

93 setup score
RS Score 80
Trend template 7/8
CANSLIM 77.0* (B)
depth pct: 1.5 base days: 35 prior uptrend pct: 68.1 weekly close spread pct: 1.0 vol dried: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 7/8 confirmed
Why This Setup? D+W Confluence
Flat Base · schematic

Flat Base: 35d base, depth 1.5%, prior uptrend 68%. Pivot $72.62. | Strong trend (7/8) | Top RS (80) | High-confidence pattern (100%) | Stage 2 | Tight base (10 tight wks) | Readiness 79/100 (watch) | CANSLIM 77.0 (B)

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • A relative-strength leader — partly met RS rank 76 — middling
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 1.1× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $72.08 vs SMA150 $60.51 / SMA200 $61.21
SMA 150 above SMA 200 SMA150 $60.51 vs SMA200 $61.21
SMA 200 trending up Slope +1.19 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $71.93
Price above SMA 50 $72.08 vs SMA50 $71.93
30%+ above 52-week low +66.9% from $43.19
Within 25% of 52-week high -0.7% from $72.62
RS score above 70 RS 80

Fundamentals

52W Range
98%
Mkt Cap SEC
11.3B
Rev YoY
-0%
EPS TTM
$1.16
P/E TTM
62.1x
Float
157M

Company

Company profile
Bio-Techne Corp
TECH · NASDAQ · Health Technology · Biotechnology
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 77.0* CANSLIM * disqualified on M
C · Curr. EPS
70
A · Annual EPS
54
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
80
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
95
W. Support
$43.19
W. Resist
$72.62
W. Patterns
Cup & Handle
Weekly Structure

Scan History

20× streak
Sep 09: 96 (Three Weeks Tight)Sep 10: 95 (Three Weeks Tight)Sep 10: 96 (Three Weeks Tight)Sep 11: 90 (Flat Base)Sep 11: 93 (Flat Base)Sep 11: 93 (Flat Base)93
Sep 11
Flat Base ✓ Gate
93
Sep 11
Flat Base ✓ Gate
93
Sep 11
Flat Base ✓ Gate
90
Sep 10
Three Weeks Tight ✓ Gate
96 0.0%
Sep 10
Three Weeks Tight ✓ Gate
95 0.0%
Sep 09
Three Weeks Tight ✓ Gate
96 -0.2%

Get the full picture on TECH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial